Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey
ROOPE L. et al, (2020), BMC Medicine
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.
Marshall DA. et al, (2020), Value Health, 23, 566 - 573
MORRISON M. et al, (2020), Secondary Findings in Genomic Research, 155 - 201
A review of health economic studies comparing traditional and massively parallel sequencing diagnostic pathways for suspected genetic disorders
Fahr P. et al, (2019), PharmacoEconomics
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK.
Yang Y. et al, (2019), Pharmacoecon Open, 3, 281 - 291
The complete costs of genome sequencing: A micro-costing study in cancer and rare diseases from a single centre in the United Kingdom
BUCHANAN J. et al, (2019), Genetics in Medicine
Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice Experiment.
Copsey B. et al, (2019), Med Decis Making
Roope LSJ. et al, (2019), Science, 364
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.
Fahr P. et al, (2019), Appl Health Econ Health Policy
Leal J. et al, (2019), Pharmacoeconomics
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions (vol 21, pg 1033, 2018)
Wordsworth S. and Buchanan J., (2019), VALUE IN HEALTH, 22, 383 - 383
Measuring the Economic Value of Sequencing: Why is it Important, Why is it Challenging, and What are Solutions
Phillips KA. et al, (2018), JOURNAL OF MOLECULAR DIAGNOSTICS, 20, 903 - 903
Buchanan J. and Wordsworth S., (2018), Pharmacoecon Open
Buchanan J., (2018), PUBLIC HEALTH GENOMICS, 21, 7 - 7
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions
Regier DA. et al, (2018), Value in Health
Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Wordsworth S. et al, (2018), Value in Health
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
Phillips KA. et al, (2018), Value in Health
Leal J. et al, (2018), Pharmacoeconomics
ARE WHOLE EXOME AND WHOLE GENOME SEQUENCING APPROACHES COSTEFFECTIVE? A SYSTEMATIC REVIEW OF THE LITERATURE
Schwarze K. et al, (2018), VALUE IN HEALTH, 21, S100 - S100
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
Schwarze K. et al, (2018), Genet Med